Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38072
CAS Number:
71320-77-9
Moclobémide
Purity:
≥ 98 % (HPLC)
Synonym(s):
4-Chloro- N -[2-(4-morpholinyl)éthyl]benzamide, 4-Chloro- N -(2-morpholinoéthyl)benzamide
Documents
$169.65 /10 mg
Taille
Request Bulk Quote
Informations sur le produit

Moclobemide is a reversible inhibitor of monoamine oxidase A (RIMA) that is primarily used in the treatment of depression and anxiety disorders. This compound is recognized for its ability to enhance mood by increasing the levels of neurotransmitters such as serotonin and norepinephrine in the brain. Its unique mechanism of action allows for a more favorable side effect profile compared to traditional irreversible MAO inhibitors, making it a preferred choice for patients who may be sensitive to the side effects of other antidepressants.

In addition to its psychiatric applications, Moclobemide has shown potential in treating social anxiety and panic disorders, providing relief for individuals who struggle with these conditions. Researchers are also exploring its neuroprotective properties, which may offer benefits in the context of neurodegenerative diseases. With its targeted action and improved tolerability, Moclobemide stands out as a valuable option for healthcare professionals seeking effective treatment alternatives for mood disorders.

Numéro CAS 
71320-77-9
Formule moléculaire
C13H17ClN2O2
Poids moléculaire 
268.74
Point de fusion 
136 - 140 °C
Informations générales
Numéro CAS 
71320-77-9
Formule moléculaire
C13H17ClN2O2
Poids moléculaire 
268.74
Point de fusion 
136 - 140 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Moclobemide is widely utilized in research focused on:

  • Antidepressant Therapy: Primarily used as a reversible inhibitor of monoamine oxidase A (RIMA), it offers a treatment option for patients with depression, providing a favorable side effect profile compared to traditional MAO inhibitors.
  • Anxiety Disorders: Effective in managing anxiety, moclobemide helps alleviate symptoms without the sedation often associated with other anxiolytics, making it suitable for patients needing to maintain daily functioning.
  • Neurological Research: Its mechanism of action is studied in various neurological conditions, providing insights into serotonin and norepinephrine pathways, which can lead to innovative treatments.
  • Pharmaceutical Development: Used as a reference compound in drug formulation studies, moclobemide aids in the development of new antidepressants with improved efficacy and safety profiles.
  • Psychiatric Studies: Researchers investigate its effects on mood and cognition, contributing to a better understanding of mental health disorders and the development of personalized treatment plans.

Citations